DK0586621T3 - Linsidomin til behandling af erektile dysfunktioner - Google Patents

Linsidomin til behandling af erektile dysfunktioner

Info

Publication number: DK0586621T3
Authority: DK; Denmark
Prior art keywords: pct; treatment; sec; combination; date
Prior art date: 1991-05-27

Application number

DK92924464T

Other languages

Danish (da)

English (en)

Inventor

Christian Dr Stief

Original Assignee

Christian Dr Stief

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-27

Filing date

1992-05-14

Publication date

2000-09-18

1992-05-14 Application filed by Christian Dr Stief filed Critical Christian Dr Stief

2000-09-18 Application granted granted Critical

2000-09-18 Publication of DK0586621T3 publication Critical patent/DK0586621T3/da

Links

208000010228 Erectile Dysfunction Diseases 0.000 title abstract 2
201000001881 impotence Diseases 0.000 title abstract 2
239000013543 active substance Substances 0.000 abstract 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 abstract 2
239000002126 C01EB10 - Adenosine Substances 0.000 abstract 1
229940127291 Calcium channel antagonist Drugs 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
229960005305 adenosine Drugs 0.000 abstract 1
239000000645 desinfectant Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
FKDHHVKWGRFRTG-UHFFFAOYSA-N linsidomine Chemical compound [N-]1OC(=N)C=[N+]1N1CCOCC1 FKDHHVKWGRFRTG-UHFFFAOYSA-N 0.000 abstract 1
229960002006 linsidomine Drugs 0.000 abstract 1
229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
150000003180 prostaglandins Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000000050 smooth muscle relaxant Substances 0.000 abstract 1
229940088594 vitamin Drugs 0.000 abstract 1
229930003231 vitamin Natural products 0.000 abstract 1
235000013343 vitamin Nutrition 0.000 abstract 1
239000011782 vitamin Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Electrotherapy Devices (AREA)

DK92924464T 1991-05-27 1992-05-14 Linsidomin til behandling af erektile dysfunktioner DK0586621T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4117249A DE4117249C2 (de)	1991-05-27	1991-05-27	Linsidomin zur Behandlung erektiler Dysfunktionen
PCT/EP1992/001109 WO1992021346A1 (fr)	1991-05-27	1992-05-14	Linsidomine therapeutique de dysfonctionnements erectiles

Publications (1)

Publication Number	Publication Date
DK0586621T3 true DK0586621T3 (da)	2000-09-18

Family

ID=6432511

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92924464T DK0586621T3 (da)	1991-05-27	1992-05-14	Linsidomin til behandling af erektile dysfunktioner

Country Status (11)

Country	Link
US (1)	US5492911A (fr)
EP (1)	EP0586621B1 (fr)
AT (1)	ATE195870T1 (fr)
AU (1)	AU1877992A (fr)
CA (1)	CA2110275A1 (fr)
DE (2)	DE4117249C2 (fr)
DK (1)	DK0586621T3 (fr)
ES (1)	ES2150425T3 (fr)
GR (1)	GR3034519T3 (fr)
HU (1)	HU9303359D0 (fr)
WO (1)	WO1992021346A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5242391A (en) *	1990-04-25	1993-09-07	Alza Corporation	Urethral insert for treatment of erectile dysfunction
DE4305881C1 (de) *	1993-02-26	1994-03-03	Lohmann Therapie Syst Lts	Transdermales therapeutisches System mit Wirkstoffen, welche Stichoxid-Quellen darstellen, Verfahren zu seiner Herstellung sowie seine Verwendung
CA2215307A1 (fr) *	1995-03-14	1996-09-19	Vivus, Incorporated	Procede de prevention de la dyserection et kit correspondant
US5741511A (en) *	1995-04-12	1998-04-21	Sam Yang Co., Ltd.	Transdermal drug delivery device for treating erectile dysfunction
US5718917A (en) *	1995-12-15	1998-02-17	Harvard Scientific Corporation	PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US20020143007A1 (en) *	1996-02-02	2002-10-03	Garvey David S.	Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6469065B1 (en)	1996-02-02	2002-10-22	Nitromed, Inc.	Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6294517B1 (en)	1996-02-02	2001-09-25	Nitromed, Inc.	Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US20050065161A1 (en) *	1996-02-02	2005-03-24	Nitromed, Inc.	Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6323211B1 (en)	1996-02-02	2001-11-27	Nitromed, Inc.	Compositions and methods for treating sexual dysfunctions
USRE37234E1 (en) *	1996-11-01	2001-06-19	Nitromed, Inc.	Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US6331543B1 (en)	1996-11-01	2001-12-18	Nitromed, Inc.	Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US5958926A (en) *	1996-11-01	1999-09-28	Nitromed, Inc.	Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US5939090A (en) *	1996-12-03	1999-08-17	3M Innovative Properties Company	Gel formulations for topical drug delivery
US6472425B1 (en)	1997-10-31	2002-10-29	Nitromed, Inc.	Methods for treating female sexual dysfunctions
FR2774594A1 (fr) *	1998-02-12	1999-08-13	Philippe Gorny	Medicament destine notamment a prevenir ou traiter les dysfonctions erectiles
US6132753A (en) *	1998-05-01	2000-10-17	Neal R. Cutler	Treatment of sexual dysfunction in certain patient groups
US6194433B1 (en)	1998-10-05	2001-02-27	Neal R. Cutler	Sexual dysfunction in females
US6187790B1 (en)	1999-03-04	2001-02-13	Neal R. Cutler	Use of cilostazol for treatment of sexual dysfunction
WO1999056666A1 (fr) *	1998-05-01	1999-11-11	Rt Alamo Ventures, Inc.	Traitement des troubles de la sexualite chez certains groupes de patients
US6426084B1 (en) *	2000-06-19	2002-07-30	Neal R. Cutler	Treatment of sexual dysfunction in certain patient groups
US6132757A (en)	1998-05-01	2000-10-17	Neal R. Cutler	Treatment of sexual dysfunction in certain patient groups
US6110489A (en) *	1998-05-01	2000-08-29	Cutler; Neal R.	Use of quinolines and quinolones to treat male erectile dysfunction
US5942545A (en) *	1998-06-15	1999-08-24	Macrochem Corporation	Composition and method for treating penile erectile dysfunction
CA2335055A1 (fr) *	1998-06-19	1999-12-23	Jack Fellman	Dispositif medical a proprietes anti-infectieuses et contraceptives
US7087240B1 (en)	1998-06-25	2006-08-08	Lavipharm Laboratories Inc.	Device and method for the treatment of erectile dysfunction
HUP0103206A3 (en)	1998-06-25	2002-11-28	Lavipharm Lab Inc Piscataway	A device and method for the treatment of erectile dysfunction and for its making
FR2786699B1 (fr) *	1998-12-02	2002-10-04	Philippe Gorny	Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
US6627632B2 (en)	1998-12-14	2003-09-30	Cellegy Pharmaceuticals, Inc.	Compositions and methods for the treatment of anorectal disorders
US6395736B1 (en) *	1998-12-14	2002-05-28	Cellegy Pharmaceuticals, Inc.	Compositions and methods for the treatment of anorectal disorders
US7176238B1 (en)	1999-03-01	2007-02-13	Nitromed Inc.	Nitrostated and nitrosylated prostaglandins, compositions and methods of use
FR2793689B1 (fr) *	1999-05-19	2001-08-24	Pf Medicament	Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
US6838050B1 (en)	1999-06-04	2005-01-04	Oxibio, Inc.	Methods and devices for providing anti-infective activity to a medical device
US6303135B1 (en)	1999-07-08	2001-10-16	Neal R. Cutler	Use of quinolines and quinolones to treat male erectile dysfunction
US6436944B1 (en) *	1999-09-30	2002-08-20	Pfizer Inc.	Combination effective for the treatment of impotence
DE10021894A1 (de) *	2000-05-05	2001-11-29	Ilias Papadopoulos	Pharmazeutisches Präparat zur Diagnose und Behandlung der erektilen Dysfunktion
DE10111516A1 (de) *	2001-03-09	2002-09-12	Judith Carlen	Verwendung von Sydnoniminen zur spezifischen Diagnose erektiler Dysfunktionen
US20090197892A1 (en) *	2007-08-21	2009-08-06	Nawaz Ahmad	Anhydrous compositions useful for attaining enhanced sexual wellness

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1496056A (fr) *	1964-06-08	1967-09-29	Takeda Chemical Industries Ltd	Nouveaux composés chimiques du type sydnonimine
JPS5832870A (ja) *	1981-08-24	1983-02-25	Hiroyoshi Hidaka	新規なシドノンイミン誘導体及びその製法
JPS60156671A (ja) *	1984-01-25	1985-08-16	Yamanouchi Pharmaceut Co Ltd	ジヒドロピリジン誘導体およびその製造法
US4840952A (en) *	1985-11-01	1989-06-20	Bristol-Myers Company	Method for treatment of male impotence
US4687771A (en) *	1985-11-01	1987-08-18	Bristol-Myers Company	Method for treatment of male impotence
US4801587A (en) *	1987-03-02	1989-01-31	Gene Voss	Impotence ointment
US5256652A (en) *	1987-11-12	1993-10-26	Pharmedic Co.	Topical compositions and methods for treatment of male impotence
US4931445A (en) *	1988-10-06	1990-06-05	Irwin Goldstein	Agents for treatment of male impotence
DE3913954A1 (de) *	1989-04-27	1990-10-31	Stief Georg	Arzneimittel zur behandlung erektiler dysfunktionen
US5059603A (en) *	1989-06-12	1991-10-22	Centuries Laboratories, Inc.	Method and composition for treating impotence
FR2649613B1 (fr) *	1989-07-11	1991-09-27	Virag Ronald	Medicament vaso-actif
US5236904A (en) *	1989-09-18	1993-08-17	Senetek, Plc	Erection-inducing methods and compositions
HU212730B (en) *	1990-03-28	1996-10-28	Chinoin Gyogyszer Es Vegyeszet	Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them
DE4031373A1 (de) *	1990-10-04	1992-04-09	Cassella Ag	3-piperazino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung
US5267963A (en) *	1992-08-21	1993-12-07	Nicholas Bachynsky	Medication injection device

1991
- 1991-05-27 DE DE4117249A patent/DE4117249C2/de not_active Expired - Fee Related
1992
- 1992-05-14 DK DK92924464T patent/DK0586621T3/da active
- 1992-05-14 DE DE59209860T patent/DE59209860D1/de not_active Expired - Fee Related
- 1992-05-14 AT AT92924464T patent/ATE195870T1/de not_active IP Right Cessation
- 1992-05-14 ES ES92924464T patent/ES2150425T3/es not_active Expired - Lifetime
- 1992-05-14 US US08/146,204 patent/US5492911A/en not_active Expired - Fee Related
- 1992-05-14 CA CA002110275A patent/CA2110275A1/fr not_active Abandoned
- 1992-05-14 HU HU9303359A patent/HU9303359D0/hu unknown
- 1992-05-14 EP EP92924464A patent/EP0586621B1/fr not_active Expired - Lifetime
- 1992-05-14 AU AU18779/92A patent/AU1877992A/en not_active Abandoned
- 1992-05-14 WO PCT/EP1992/001109 patent/WO1992021346A1/fr active IP Right Grant
2000
- 2000-09-29 GR GR20000402209T patent/GR3034519T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0586621B1 (fr)	2000-08-30
DE4117249A1 (de)	1992-12-03
ATE195870T1 (de)	2000-09-15
WO1992021346A1 (fr)	1992-12-10
CA2110275A1 (fr)	1992-12-10
DE4117249C2 (de)	1998-05-14
HU9303359D0 (en)	1994-03-28
EP0586621A1 (fr)	1994-03-16
ES2150425T3 (es)	2000-12-01
AU1877992A (en)	1993-01-08
GR3034519T3 (en)	2000-12-29
US5492911A (en)	1996-02-20
DE59209860D1 (de)	2000-10-05

Similar Documents

Publication	Publication Date	Title
DK0586621T3 (da)	2000-09-18	Linsidomin til behandling af erektile dysfunktioner
ES2603086T3 (es)	2017-02-23	Uso de la daptomicina
BR0108379A (pt)	2002-11-05	Composições de liberação controlada contendo agonista e antagonista opióide, método para a preparação de uma formulação em dosagem de analgésico opióide de liberação controlada com potência analgésica aumentada e sistema de administração através da derme para um analgésico opióide
BR0115392A (pt)	2004-06-15	Método para o tratamento de uma doença sensìvel a interferona em um animal de sangue quente, método para individualizar as dosagens de uma interferona no tratamento, método para a fabricação de um dispositivo de liberação de efeito terapêutico de longa duração de uma droga ao longo de um perìodo de tempo, e conjunto útil para a ministração de uma quantidade relativamente constante de uma droga
CZ176495A3 (en)	1995-12-13	The use of riluzol for preparing a medicament suitable for treating parkinson's disease and parkinson's syndromes
ZA888461B (en)	1989-08-30	Azelastine-containing medicaments for application in the nose and/or at the eye
DE60022021D1 (de)	2005-09-22	Zubereitungen enthaltend Apomorphin und Sildenafil und ihre Verwendung zur Behandlung von erektiler Dysfunktion
FI972542A0 (fi)	1997-06-16	Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten
ES2196361T3 (es)	2003-12-16	Combinaciones terapeuticas de antagonistas de rar y agonistas de rxr.
ES2171469T3 (es)	2002-09-16	Composicion administrada por via nasal y preparacion que la contiene.
NO20043871L (no)	2004-09-15	Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
AR016798A1 (es)	2001-08-01	Uso de una cepa de lactobacillus para la elaboracion de un medicamento
YU2494A (sh)	1997-01-08	Farmaceutska formulacija za tretiranje zavisnosti od nikotina
ES2168241T1 (es)	2002-06-16	Preparacion farmaceutica que contiene tolperisona para administrar por via oral.
ES2135342B1 (es)	2000-05-16	Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
MY124465A (en)	2006-06-30	Reduction of infarct volume using citicoline
MC2025A1 (fr)	1990-04-25	Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
ES2094834T3 (es)	1997-02-01	Dispositivo para el lavado, para finalidades terapeuticas o de higiene, de conductos internos humanos o animales.
KR900007434A (ko)	1990-06-01	시스타틴을 유효 성분으로하는 치료제
KR890007728A (ko)	1989-07-05	진통제 제조방법
GR3024854T3 (en)	1998-01-30	Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
ES2043567T1 (es)	1994-01-01	Una composicion farmaceutica de liberacion controlada para uso oral que contiene farmacos anti-inflamatorios no esteroideos.
SE9101341D0 (sv)	1991-05-03	New medicinal use
BR9912260A (pt)	2001-10-02	Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração
ES2146683T3 (es)	2000-08-16	Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos.